
Summit Therapeutics (SMMT) had the highest return between August 7, 2024 and September 10, 2024 by a mid-cap US stock, returning 141.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | 8/7/2024 - 9/10/2024 | 141.79% |
Sezzle (SEZL) | 8/7/2024 - 9/10/2024 | 73.35% |
Axogen (AXGN) | 8/7/2024 - 9/10/2024 | 65.66% |
Vaxcyte (PCVX) | 8/7/2024 - 9/10/2024 | 57.54% |
GPGI (GPGI) | 8/7/2024 - 9/10/2024 | 53.31% |
Applied Opt (AAOI) | 8/7/2024 - 9/10/2024 | 50.78% |
Applied Digital (APLD) | 8/7/2024 - 9/10/2024 | 50.47% |
GDS (GDS) | 8/7/2024 - 9/10/2024 | 50.04% |
Grupo Financiero Galicia SA ADR (GGAL) | 8/7/2024 - 9/10/2024 | 48.86% |
Xometry (XMTR) | 8/7/2024 - 9/10/2024 | 46.53% |
Oruka Therapeutics (ORKA) | 8/7/2024 - 9/10/2024 | 46.49% |
Nio Inc Class A ADR (NIO) | 8/7/2024 - 9/10/2024 | 43.83% |
ADMA Biologics (ADMA) | 8/7/2024 - 9/10/2024 | 42.89% |
CAVA (CAVA) | 8/7/2024 - 9/10/2024 | 42.69% |
Peloton Interactive (PTON) | 8/7/2024 - 9/10/2024 | 41.08% |
Travere Therapeutics (TVTX) | 8/7/2024 - 9/10/2024 | 40.64% |
Doximity (DOCS) | 8/7/2024 - 9/10/2024 | 38.25% |
Intapp (INTA) | 8/7/2024 - 9/10/2024 | 38.22% |
Compass (COMP) | 8/7/2024 - 9/10/2024 | 36.07% |
Amylyx Pharmaceuticals (AMLX) | 8/7/2024 - 9/10/2024 | 33.67% |
Calumet (CLMT) | 8/7/2024 - 9/10/2024 | 33.17% |
Tarsus Pharmaceuticals (TARS) | 8/7/2024 - 9/10/2024 | 32.77% |
Ast Spacemobile (ASTS) | 8/7/2024 - 9/10/2024 | 32.54% |
Semtech (SMTC) | 8/7/2024 - 9/10/2024 | 32.54% |
Zillow Group Inc Class C (Z) | 8/7/2024 - 9/10/2024 | 32.22% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.